Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Randomized Controlled Trial of Qiling Yiqi Tablets Combined With Antiretroviral Therapy for Immune Reconstitution Failure in People With HIV and Lung-Spleen Qi Deficiency Syndrome

NCT07698574 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.

NCT NCT07698574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Randomized Controlled Trial of Qiling Yiqi Tablets Combined With Antiretroviral Therapy for Immune Reconstitution Failure in People With HIV and Lung-Spleen Qi Deficiency Syndrome
Lead sponsor
Beijing University of Chinese Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
February 28, 2029
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, hiv-1 infection, immune reconstitution failure, immunological non-responder, lung-spleen qi deficiency syndrome